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ABSTRACT 
 
Flaxseed, Linum usitatissimum, is a member of the genus Linum in the family Linaceae. It is a food and fiber crop 
cultivated in cooler regions of the world. The aim of this study is to overview its anti-cancer and anti-tumor effects. 
This review article was carried out by searching studies in PubMed, Medline, Web of Science, and IranMedex 
databases up to 2016.totally, of 108 found articles, 41 articles were included. The search terms were “Flaxseed.  ”, 
“therapeutic”, “pharmacological”, anticancer, anti-tumor. Various studies have shown that Flaxseed. Possess 
Anti-Breast Cancer properties, Anti-Breast tumors properties , Anti-Ovary cancer properties, Gut-associated 
diseases properties, Lung tumor properties, Inflammation properties, Anti-Skin Carcinogenesis properties, Pro-
carcinogenic, Mastalgia properties, Aortic remodeling ,Anti-mammary Cancer effect ,Antioxidant and 
Antiproliferative ,Colon cancer properties, Esophagitis  properties, Apoptosis  properties. Flaxseed possess lots of 
therapeutic and pharmacological effects.in this study, its anticancer, anti-tumor effects was overviewed. 
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INTRODUCTION 
 
It is proved that herbal medicine is effective in the treatment of many diseases [1-10].Flax, Linum usitatissimum, is a 
member of the genus Linum in the family Linaceae. It is a food and fiber crop cultivated in cooler regions of the 
world. Flax was extensively cultivated in ancient Egypt, where the temple walls had paintings of flowering flax, and 
mummies were entombed in linen.  
 
The textiles made from flax are known in the Western countries as linen, and traditionally used for bed sheets, 
underclothes, and table linen. The oil is known as linseed oil. In addition to referring to the plant itself, the word 
"flax" may refer to the unspun fibers of the flax plant. The plant species is known only as a cultivated plant, and 
appears to have been domesticated just once from the wild species Linumbienne, called pale flax[1-4].  
 
Several other species in the genus Linum are similar in appearance to L. usitatissimum, cultivated flax, including 
some that have similar blue flowers, and others with white, yellow, or red flowers. Some of these are perennial 
plants, unlike L. usitatissimum, which is an annual plant[5]. 
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Flax is grown for its oil, used as a nutritional supplement, and as an ingredient in many wood-finishing products. 
Flax is also grown as an ornamental plant in gardens. Flax fibers are used to make linen. The Latin species 
name usitatissimum means "most useful"[6,7]. 
 
Flax fibers are taken from the stem of the plant, and are two to three times as strong as those of cotton. Additionally, 
flax fibers are naturally smooth and straight. Europe and North America depended on flax for vegetable-based cloth 
until the 19th century, when cotton overtook flax as the most common plant used for making rag-based paper. Flax 
is grown on the Canadian prairies for linseed oil, which is used as a drying oil in paints and varnishes and in 
products such as linoleum and printing inks[8-10].  
 
Breast Cancer prevention 
The effect of the phenolic extract from FS oil has been evaluated on two human breast cancer cell lines and on the 
human non-cancerous breast cell line. The extract shows anti-proliferative activity on MCF7 cells by inducing 
cellular apoptosis, increase of the percentage of cells in G0/G1 phase and of lipid peroxidation, activation of the 
H2AX signaling pathway, and upregulation of a six gene signature. The data suggest that the extract has both 
cytotoxic and pro-oxidant effects only on MCF7 cells, and can act as a metabolic probe, inducing differences in the 
gene expression. [11].  
 
The association between intake of flaxseed-the richest source of dietary lignans [a class of phytoestrogens]-and 
breast cancer risk was investigated. It has found that flaxseed intake is associated with a reduction in breast cancer 
risk. As dietary intake of flaxseed is modifiable, this finding may be of public health importance with respect to 
breast cancer prevention [12]. 
 
By using microdialysis in a model of human breast cancers in nude mice, species-specific analyses of released 
proteins in the microenvironment was carried out. It showed that tumors treated with tamoxifen and fed Flax or ENL 
exhibited decreased in vivo release of IL-1β derived from the murine stroma and decreased microvessel density 
whereas dietary GEN had no effects. It conclude that the release of IL-1s both by cancer cells and the stroma, where 
macrophages are a key component, may offer feasible targets for antiestrogen therapy and dietary interventions 
against breast cancer[13]. 
 
In an animal study, combining dietary FO (8%) compared with TRAS treatment (2.5 or 5mg/kg body weight) on 
established human breast tumors overexpressing HER2 (BT-474). Combined TRAS2.5 treatment with FO caused a 
significantly lower tumor cell proliferation and higher apoptosis compared to TRAS2.5 treatment alone and showed 
similar effect to TRAS5 treatment with or without FO. Thus, FO did not interfere with TRAS but rather enhanced its 
tumor-reducing effects and combined FO and low dose TRAS was as effective as high dose TRAS treatment [14]. 
 
An extraction procedure for lignans from flaxseed was investigated. The ability of these two compounds and that of 
secoisolariciresinol diglucoside to modulate the growth of human breast cancer MCF-7 and MDA-MB-231 cell lines 
was assessed. Results show that lignans modulate development of breast cancer cells. The most intense effect was 
observed for anhydrous ecoisolariciresinol, which significantly decreased cell growth at 50 and 100 microM [15]. 
 
Mammary and ovarian cancer progression were induced using local ovarian DMBA treatment and subcutaneous 
sustained release 17β-estradiol administered starting at 7 weeks of age. Treatment with SDG normalized several 
biomarkers in mammary gland tissue (dysplasia, cell number, and expression of several genes) that had been altered 
by carcinogen. There is no indication that SDG promotes preneoplastic progression in the ovarian epithelium [21]. 
 
The efficacy of tamoxifen, anti-estrogen treatments for breast cancer affected some of the most important 
endogenous angiogenesis regulators was evaluated. Results showed that one of the mechanisms of tamoxifen in 
normal breast tissue include tipping of the angiogenic balance into an anti-angiogenic state and that flaxseed has 
limited effects on the pro-angiogenic factors whereas the anti-angiogenic endostatin may be modified by diet. 
Further studies of diet modifications for breast cancer prevention are warranted [23]. 
 
In vitro, co-culture of breast cancer cells and primary human adipocytes was used. The levels of leptin decreased 
and adiponectin increased after a dietary addition of 25 g of flaxseed/day for one menstrual cycle. We conclude that 
VEGF and leptin correlate significantly in normal human breast tissue in vivo and that dietary addition of flaxseed 
affect adipokine levels in the breast [24].  
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Breast tumor prevention 
the effects of SDG and SES on established human estrogen receptor-positive breast tumors (MCF-7) was 
differentiate in athymic mice with high serum estrogen to help explain the different effects. At high serum estrogen 
levels, SDG may not account for the tumor reducing effect of FS. SES was more effective than SDG in reducing 
breast tumor growth, but its effect may have been lost when consumed as a component of SS [27]. 
 
Flaxseed (FS) reduces breast tumor genesis and human epidermal growth factor receptor 2 (HER2) expression in 
postmenopausal patients and animal models. TRAS reduces tumor growth by influencing HER2 signaling. Dietary 
FS has minimal tumor-reducing effect, does not interfere with TRAS action, but improves overall survival in 
athymic mice [28]. 
 
the effect of 4% FSO alone and combined with TRAS on HER2-overexpressing tumor (BT-474) growth and to 
explore potential mechanisms with a specific focus on HER2, mitogen-activated protein kinase (MAPK) and Akt 
signaling and fatty acid profile was determined. Dietary FSO alone does not affect BT-474 tumor growth but 
enhances the tumor-reducing effect of TRAS (2.5 mg/kg). FSO alters tumor fatty acid profile that likely contributes 
to effects on signaling pathways. This supports FSO as a complementary treatment for HER2+ breast cancer treated 
with TRAS [29]. 
 
The in vitro effects of flaxseed sprouts on cell growth and apoptosis of human breast cancer cells was investigated. 
The results suggest that flaxseed sprouts induce apoptosis and inhibit cancer cell growth, thereby demonstrating 
their anti-proliferative effects in breast cancer cells. This study may provide important information for devising 
dietary strategies to reduce breast cancer risk [31]. 
 
The phytoestrogen properties of the components of flaxseed Linum Usitatissimum L., especially lignans and 
products of their biotransformation in humans and animals enterodiol (END) and enterolactone (ENL) are presented. 
The antioxidant activity of SIR, END, ENL and SIR-DG is higher than that of vitamin E and the antioxidant activity 
of SIR, END and ENL higher than SIR-DG. Finally, in epidemiological studies have proved the anticarcinogenic 
activity of the components of the flaxseed and validity of recommendations for preventive and curative use in 
hormone-dependent tumors [32]. 
 
Flaxseed, a rich source of dietary lignans, may be a potentially effective treatment of hot flashes. A phase III, 
randomized, placebo, controlled trial was conducted to evaluate the efficacy of flaxseed in reducing hot flashes. The 
results of this trial do not support the use of 410 mg of lignans for the reduction of hot flashes. The bars were fairly 
well tolerated, with both groups reporting gastrointestinal effects, probably due to the fiber content [33]. 
 
The effects of SDG and FO, alone or in combination, on BMC, BMD, and biomechanical bone strength in 
ovariectomized athymic mice with established human breast tumors (MCF-7) treated with or without TAM were 
studied. FS components did not significantly attenuate the positive effects on bone induced by TAM in this model 
system, indicating no apparent adverse effects on bone health [34]. 
 
n-3 fatty acid-rich cotyledon fraction of FS (FC), alone or in combination with TAM, has a similar effect and thus 
can substitute for FS. FC reduced the growth of ER+ human breast tumours at low circulating E2, alone and 
combined with TAM, in part through modulation of ER- and growth factor-mediated signalling pathways; it may 
substitute for FS in increasing the effectiveness of TAM [36]. 
 
Anti-Ovary cancer 
The independent effects of the two flaxseed components on estrogen signaling and metabolism was examined. Some 
targets involved in the IGF/insulin signaling pathway (IRS1, IGFBP4, IGFBP5) were downregulated by flaxseed 
and its components. Flaxseed diet also downregulated AKT expression. The weak anti-estrogens, enterolactone, 
enterodiol and 2-methoxyestradiol, might be working synergistically to generate a protective effect on the ovaries 
from hens on whole flaxseed diet by altering the estrogen signaling and metabolism [16].  
 
Gut-associated diseases 
The efficacy of FS on altering critical aspects of gut health in healthy unchallenged mice was evaluated. muciniphila 
abundance by FS was also demonstrated in the colon tissue-associated microbiota (quantitative PCR). Furthermore, 
fecal branched chain fatty acids were increased by FS, indicative of increased microbial-derived putrefactive 
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compounds. In conclusion, consumption of a FS-supplemented diet alters the baseline colonic microenvironment of 
healthy mice which may modify subsequent mucosal microbial defense and injury-repair responses leading to 
altered susceptibility to different gut-associated diseases [17].  
 
Lung tumor 
cultured metastatic tumor cells were injected into the C57BL/6 mice through tail-vein injection (TVI) and the anti-
metastatic properties of flax seed oil (FSO) were evaluated. These results support the protective role of FSO against 
lung cancer metastasis [18]. 
 
Inflammation 
The ability of flaxseed lignan component (FLC) to prevent acute asbestos-induced inflammation in MM-prone Nf2 
(+/mu) mice was tested. Results showed that FLC reduces acute asbestos-induced peritoneal inflammation, 
nitrosative and oxidative stress and may thus prove to be a promising agent in the chemoprevention of MM [19].  
 
Anti-Skin Carcinogenesis 
The potential of flaxseed oil to prevent chemically induced skin cancer in mice was evaluated. The results of the 
present study demonstrate that the oral administration of FSO has the potential to modulate the levels of LPO, 
antioxidants, and detoxification enzymes in the DMBA-croton oil-induced skin carcinogenesis in mice [20]. 
 
Pro-carcinogenic 
The optimum dose of flaxseed that would decrease PG and alter oestrogen pathway endpoints implicated in ovarian 
cancer was found. The findings showed that Flaxseed decreased the expression of ERα in the ovaries. The ratio of 2-
OHE1:16-OHE1 in the serum increased significantly in the 15% flaxseed diet, and there was a corresponding 
increase in CYP1A1 in the liver and decrease in CYP3A4 in the ovaries. CYP1B1 mRNA also decreased with 
flaxseed diet in the ovaries. The 15% flaxseed-supplemented diet significantly decreased inflammatory PGE2, ERα, 
CYP3A4, CYP1B1 and 16-OHE1, but it increased CYP1A1 and 2-OHE1, which thus reduced the inflammatory and 
pro-carcinogenic micro-environment of the ovaries [22]. 
 
Mastalgia 
The efficacy of V. agnus and Flaxseed on cyclical mastalgia. This randomized controlled trial was conducted on 159 
women referred to health centers of Tabriz, Iran. Subjects were allocated into three groups (n=53 per group) using 
block randomization was assessed. Flaxseed and V. agnus are effective in short-term period in decreasing cyclical 
mastalgia. However, further studies are needed to examine the long-term effectiveness and sustainability of the 
effects after stopping the treatment in order to decide whether these alternative treatments are suitable to treat 
mastalgia or not [25]. 
 
Aortic remodeling  
The influence of flaxseed flour and oil on cardiovascular biochemical parameters was evaluated and the 
histoarchitecture of the aorta in adult rats which were offspring of diabetic mothers. The data suggest that the use of 
both flaxseed flour and its oil reduces the remodeling of the aorta; however; it has not been possible to modify the 
cardiovascular biochemical parameters [26]. 
 
Anti-mammary Cancer effect  
Low flaxseed doses relevant to human dietary exposure can prevent mammary tumors in transgenic Tg was 
investigated. The number of tumor-bearing mice and multiplicity of tumors at necropsy were not statistically 
significantly lower compared to the controls. Thus, the effect of small dietary doses of flaxseed on mammary tumor 
development in Tg. NK mice remains to be established [35]. 
 
Antioxidant and antiproliferative  
Lignan biosynthesis and potential health benefits in flaxseeds during 10-day germination was examined. Results 
showed that the highest antioxidant and antiproliferative activities were found on day 10. These findings suggest that 
germination for 8-10days leads to optimal lignan production and potential health benefits if incorporated into the 
human diet [37].  
 
The effect of Tocopherols, the main oilseeds natural antioxidants on cell membranes was investigated. The results 
clearly showed that utilization of polar solvent enable extraction of significant amounts of phenolics and flavonoids. 
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Those components were the most potent antioxidants present in those extracts. Content of these compounds 
correlated well with results from applied methods for antioxidant assessment [40]. 
 
Colon cancer  
The influence of flaxseed (Linum usitatissimum L.) and its total non-digestible fraction (TNDF) on the expression of 
genes involved in azoxymethane (AOM)-induced colon cancer in Sprague Dawley rats was analyzed. Finding 
suggests that both of these treatments induced cell cycle arrest. In addition, TNDF induced mitochondrial apoptosis 
because the TNDF + AOM group exhibited the expression of caspase-3, decreased bcl-2 expression and increased 
bax expression. These results suggest that the expression of the analyzed genes is associated with the presence of 
dietary antioxidants linked to the cell wall of flaxseed [38]. 
 
Esophagitis  
The present study was undertaken to elucidate the effect of Linum usitatissimum fixed oil on experimental 
esophagitis in albino rats. The lipoxygenase inhibitory, histamine antagonistic, antisecretory (anticholinergic) and 
antioxidant activity of the oil was attributed for its effect in reflux esophagitis [39]. 
 
Apoptosis  
Antioxidant and antiapoptotic effects of flax seed oil (FSO) on rats exposed to ultraviolet C (UVC)was determined. 
This investigation demonstrated that UVC exposure led to oxidative stress and apoptosis in rats as reflected by 
increased MDA, PC contents and decreased enzymatic and no enzymatic antioxidant levels, FSO may be useful for 
preventing photo reactive damage [41]. 
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